Companies: 10,795·Total market cap: $144.5T
Medexus Pharmaceuticals Inc.

Medexus Pharmaceuticals Inc.

MDP.TOTSXHealthcare● Active
$3.94
+$0.03(+0.77%)
Market Cap$127263497
P/E Ratio
52W High$4.17
52W Low$2.47

Medexus Pharmaceuticals Inc.(MDP.TO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MDP.TO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-032024-032023-032022-032021-03
Revenue
Revenue$0.11B$0.11B$0.11B$0.08B$0.08B
Cost of Revenue$0.05B$0.05B$0.05B$0.04B$0.04B
Gross Profit$0.06B$0.06B$0.06B$0.04B$0.04B
Gross Margin %(computed)52.23%52.64%55.54%49.45%52.73%
Operating Expenses
R&D Expenses$0.01B$0.01B$0.00B$0.01B$0.00B
G&A Expenses$0.03B$0.03B$0.04B$0.03B$0.02B
Total Operating Expenses$0.05B$0.05B$0.05B$0.05B$0.04B
Operating Income$0.01B$0.01B$0.01B($0.01B)($0.00B)
Operating Margin %(computed)7.59%9.55%7.04%-16.14%-1.73%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.01B$0.01B
Income Before Tax$0.00B$0.00B($0.01B)($0.00B)($0.03B)
Income Tax Expense($0.00B)$0.00B($0.01B)($0.00B)($0.00B)
Net Income$0.00B($0.00B)$0.00B($0.00B)($0.03B)
Net Margin %(computed)2.07%-0.19%1.13%-3.75%-35.48%
Per Share & EBITDA
EPS (Basic)$0.09$-0.01$0.08$-0.19$-1.86
Wtd Avg Shares0.03B0.02B0.02B0.02B0.02B
EBITDA$0.02B$0.02B$0.01B$0.01B($0.02B)
EBITDA Margin %(computed)15.52%17.05%13.55%18.97%-29.63%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Medexus Pharmaceuticals Inc.

关于Medexus Pharmaceuticals Inc.(MDP.TO)损益表

Medexus Pharmaceuticals Inc.(MDP.TO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MDP.TO实现营收$0.11B,毛利润$0.06B(毛利率52.23%),净利润$0.00B(净利率2.07%)。

常见问题

MDP.TO · 4 问

Medexus Pharmaceuticals Inc.(MDP.TO)2025财年营收为$0.11B,同比down4.2%。

MDP.TO revenueMDP.TO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08